2m 2m 2m 2m 2m 2m 2m
LUCID DIAGNOSTCS (LUCD)
NASDAQ
$1.02+$0.02 (+1.59%)
Price as of Jun 03, 2026 7:55 PM EDT- $196.5MMarket Cap
- -18.25%1-Year Change
- Medical DevicesIndustry
LUCID DIAGNOSTCS (LUCD)
$1.02+$0.02 (+1.59%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.7M +8.28% | 4.3M +79.00% | 2.4M N/A | N/A N/A | |
Cost of Revenue | 6.7M N/A | N/A N/A | N/A N/A | 23,000 -96.07% | |
Gross Profit | -2.0M -145.19% | 4.3M +79.00% | 2.4M +544.03% | 377,000 +543.53% | |
Sales and Marketing Expense | 17.7M +7.57% | 16.5M +0.36% | 16.4M +1.67% | 16.1M +206.73% | |
Research and Development Expense | -5.7M -5.24% | -6.0M -17.37% | -7.3M -36.75% | -11.5M +23.34% | |
Depreciation and Amortization Expense | 872,000 -25.28% | 1.2M -53.30% | 2.5M +29.08% | 1.9M +48,300.00% | |
Total Operating Expenses | 54.3M +7.83% | 50.4M -1.01% | 50.9M -9.97% | 56.5M +106.88% | |
Operating Profit | -49.6M +7.79% | -46.1M -5.01% | -48.5M -13.69% | -56.2M +104.86% | |
Interest Income | 386,000 +19.88% | 322,000 -24.06% | 424,000 N/A | N/A N/A | |
Interest Expense | N/A N/A | -26,000 -93.75% | -416,000 N/A | N/A N/A | |
Interest Income and Expense and Net | 386,000 +30.41% | 296,000 +3,600.00% | 8,000 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | -8.4M -1,700.38% | 523,000 +112.50% | -4.2M N/A | N/A N/A | |
Income before Taxes | -58.0M +27.41% | -45.5M -13.55% | -52.7M -6.24% | -56.2M +100.05% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -58.0M +9.40% | -53.0M +0.68% | -52.7M -6.24% | -56.2M +100.05% | |
Net Income from Continuing Operations Applicable to Common | -70.6M +33.09% | -53.0M +0.68% | -52.7M -6.24% | -56.2M +100.05% | |
Basic EPS and Net Income | -0.69 -34.29% | -1.05 -16.67% | -1.26 -18.71% | -1.55 +2.65% | |
Diluted EPS and Net Income | -0.69 -34.29% | -1.05 -16.67% | -1.26 -18.71% | -1.55 +2.65% | |
Basic Weighted Average Shares | 101.9M +101.81% | 50.5M +20.98% | 41.8M +15.44% | 36.2M +94.44% | |
Diluted Weighted Average Shares | 101.9M +101.81% | 50.5M +20.98% | 41.8M +15.44% | 36.2M +94.44% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 34.7M +55.22% | 22.4M +18.32% | 18.9M -15.92% | 22.5M -58.11% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 34.7M +55.22% | 22.4M +18.32% | 18.9M -15.92% | 22.5M -58.11% | |
Total Current Assets | 37.5M +48.99% | 25.1M +13.93% | 22.1M -9.37% | 24.4M -57.50% | |
Accumulated Depreciation | 1.6M +37.93% | 1.1M +49.54% | 767,000 +165.40% | 289,000 +7,125.00% | |
Property and Plant and Equipment and Net | 809,000 -23.82% | 1.1M -20.39% | 1.3M -16.21% | 1.6M +63.95% | |
Total Long-Term Assets | 47,000 -95.85% | 1.1M 0.00% | 1.1M +2.17% | 1.1M +52.83% | |
Total Assets | 40.4M +31.68% | 30.7M +12.63% | 27.3M -16.12% | 32.5M -44.90% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 24.0M +29.03% | 18.6M +33.33% | 13.9M N/A | N/A N/A | |
Total Current Liabilities | 28.6M +21.50% | 23.5M -19.94% | 29.4M +248.75% | 8.4M +465.44% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 927,000 -48.50% | 1.8M +804.52% | 199,000 -80.81% | 1.0M N/A | |
Total Liabilities | 29.5M +16.53% | 25.3M -14.39% | 29.6M +212.63% | 9.5M +122.11% | |
Retained Earnings | -274.3M +34.63% | -203.8M +35.18% | -150.7M +53.70% | -98.1M +134.05% | |
Total Stockholders Equity | 10.9M +102.86% | 5.4M +333.28% | -2.3M -110.03% | 23.0M -57.90% | |
Total Shares Outstanding | 131.1M +107.86% | 63.1M +49.00% | 42.3M +4.47% | 40.5M +16.04% | |
Cash Flow | |||||
Cash from Operating Activities | -46.5M +5.31% | -44.1M +34.50% | -32.8M +10.55% | -29.7M +68.02% | |
Capital Expenditures | 197,000 N/A | N/A N/A | N/A N/A | 3.2M +271.23% | |
Cash from Investing Activities | -197,000 -69.50% | -646,000 +192.31% | -221,000 -94.62% | -4.1M +376.57% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 59.0M +22.34% | 48.2M +63.77% | 29.5M +1,028.30% | 2.6M -96.38% | |
Financials Ratio | |||||
Gross Margin | -41.73% N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,054.82% -0.45% | -1,059.64% -46.93% | -1,996.79% N/A | N/A N/A | |
Return on Assets | -163.04% -10.85% | -182.89% +3.80% | -176.20% +43.53% | -122.77% N/A | |
Return on Equity | -710.60% -79.36% | -3,443.18% +577.84% | -507.97% +251.72% | -144.42% N/A | |
Revenue Growth | 8.28% -89.51% | 79.00% N/A | N/A N/A | N/A N/A | |
Current Ratio | 1.31 +22.63% | 1.07 +42.31% | 0.75 -74.02% | 2.89 N/A | |
Cash Ratio | 1.21 +27.76% | 0.95 +47.78% | 0.64 -75.89% | 2.67 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow